UK markets closed

InspireMD, Inc. (NSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3650-0.0250 (-1.09%)
As of 02:19PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 55.80M
Enterprise value 18.37M
Trailing P/E 1.41
Forward P/E 11.70
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.32
Price/book (mrq)1.41
Enterprise value/revenue 2.96
Enterprise value/EBITDA 0.52

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 335.23%
S&P500 52-week change 326.16%
52-week high 33.8500
52-week low 31.5800
50-day moving average 32.2448
200-day moving average 32.8005

Share statistics

Avg vol (3-month) 334.69k
Avg vol (10-day) 313.31k
Shares outstanding 523.42M
Implied shares outstanding 623.6M
Float 810.39M
% held by insiders 118.49%
% held by institutions 143.02%
Shares short (30 Apr 2024) 467.57k
Short ratio (30 Apr 2024) 41.14
Short % of float (30 Apr 2024) 40.40%
Short % of shares outstanding (30 Apr 2024) 40.29%
Shares short (prior month 28 Mar 2024) 488.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Apr 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 327 Apr 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-329.81%

Management effectiveness

Return on assets (ttm)-36.56%
Return on equity (ttm)-70.01%

Income statement

Revenue (ttm)6.21M
Revenue per share (ttm)0.26
Quarterly revenue growth (yoy)71.60%
Gross profit (ttm)N/A
EBITDA -20.91M
Net income avi to common (ttm)-19.92M
Diluted EPS (ttm)-0.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.02M
Total cash per share (mrq)1.66
Total debt (mrq)1.59M
Total debt/equity (mrq)4.04%
Current ratio (mrq)7.34
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)-16.38M
Levered free cash flow (ttm)-9.67M